ZILA--test for oral cancer? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ZILA--test for oral cancer?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Mark Fleming who wrote (53)	8/11/1996 4:20:00 PM
From: Julio P. Antelo	of 61

No news on OXYCAL. I'm beginning to think it was just wishful thinking on the part of some zealous ZILA fans. The posts I saw mentioned that it was OXYCAL that came back to the table because they need distribution for their products and since ZILA now controls BDTC that could be one way to increase their distribution channels. Even that seems a little odd since BDTC's sales force calls mainly on dentists and dental practices, perhaps not the best way to market vitamin C. Who knows. As for the liquidity of ZILA's shares, I am not expecting any adverse effects from any changes the NASDAQ implements. ZILA has been trading roughly 70,000 shares daily even during this period of almost relative "inactivity" prior to the FDA announcement. What could help the stock, though, is listing on the National Market and that shouldn't take long now that the BDTC merge is a done deal. Regards, Julio.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next